SF3B1 in chronic lymphocytic leukemia

New England Journal of Medicine

Volumn 366, Issue 11, 2012, Pages 1057-1058

  Mori, Jinichi ^a   Takahashi, Yukie ^a   Tanimoto, Tetsuya ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b University of Tokyo   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LETTER; MOLECULAR PATHOLOGY; MUTATOR GENE; PREDICTION; PRIORITY JOURNAL; SF3B1 GENE;

EID: 84858190503     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1201040     Document Type: Letter

References (2)

1. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365:2497-506.
2. Rossi D, Bruscaggin A, Spina V, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118:6904-8.